Literature DB >> 17113600

Epidemiology of depression and its treatment in the general population.

Maurice M Ohayon1.   

Abstract

This study examines the correlates of a major depressive disorder and its treatment in the general population. The sample was composed of 6694 individuals aged between 18 and 96 years, representative of the general population of the states of California and New York (48 million inhabitants aged 18 years or older). They were interviewed by telephone using the Sleep-EVAL system. The interviews included various sleep and health topics and the assessment of DSM-IV sleep and psychiatric disorders. The 1-month prevalence of a major depressive disorder was 5.2% in the sample, and was higher in women, middle-aged and non-Hispanic white individuals. Obesity (BMI > or =30kg/m(2)), poor health status and smoking were also strongly correlated with a major depressive disorder. A total of 57.7% of depressed subjects were receiving some forms of treatment for depression: 28.3% were taking antidepressants (alone or in combination with psychiatric health care) and 29.4% received psychiatric health care (without antidepressant medication). Severity of depression, ethnicity and weight (overweight or obese) were strongly associated with the presence of treatment. A major depressive disorder is frequent in the general population. Although its identification and treatment have improved over the years, some segments of the population, namely elderly and non-white individuals are less likely to receive appropriate care.

Entities:  

Mesh:

Year:  2006        PMID: 17113600     DOI: 10.1016/j.jpsychires.2006.10.006

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  42 in total

1.  Evaluation of the Mental Healthiness Aging Initiative: community program to promote awareness about mental health and aging issues.

Authors:  Faika Zanjani; Tina Kruger; Deborah Murray
Journal:  Community Ment Health J       Date:  2011-01-14

2.  The contribution of fatigue and sleepiness to depression in patients attending the sleep laboratory for evaluation of obstructive sleep apnea.

Authors:  Melinda L Jackson; Con Stough; Mark E Howard; Jo Spong; Luke A Downey; Bruce Thompson
Journal:  Sleep Breath       Date:  2010-05-06       Impact factor: 2.816

3.  Differences in the determinants of posttraumatic stress disorder and depression after a mass traumatic event.

Authors:  Melissa Tracy; Fran H Norris; Sandro Galea
Journal:  Depress Anxiety       Date:  2011-05-26       Impact factor: 6.505

4.  Longitudinal predictors of first time depression treatment utilization among adults with depressive disorders.

Authors:  Inger Burnett-Zeigler; Kara Zivin; Khairul Islam; Mark A Ilgen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-01-05       Impact factor: 4.328

5.  Preventive strategies to reduce depressive symptoms in overweight and obese young adults.

Authors:  EunSeok Cha; Betty J Braxter; Kevin H Kim; Heeyoung Lee; Margeaux K Akazawa; Molly S Talman; Melissa D Pinto; Melissa Spezia Faulkner
Journal:  Arch Psychiatr Nurs       Date:  2015-04-20       Impact factor: 2.218

6.  Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients.

Authors:  Gualberto Ruaño; David Villagra; Bonnie Szarek; Andreas Windemuth; Mohan Kocherla; Krystyna Gorowski; Christopher Berrezueta; Harold I Schwartz; John Goethe
Journal:  Biomark Med       Date:  2011-08       Impact factor: 2.851

7.  Traumatic event exposure and depression severity over time: results from a prospective cohort study in an urban area.

Authors:  Melissa Tracy; Hal Morgenstern; Kara Zivin; Allison E Aiello; Sandro Galea
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-10       Impact factor: 4.328

8.  Relationship between mood disturbance and sleep quality in oncology outpatients at the initiation of radiation therapy.

Authors:  Christina Van Onselen; Laura B Dunn; Kathryn Lee; Marylin Dodd; Theresa Koetters; Claudia West; Steven M Paul; Bradley E Aouizerat; William Wara; Patrick Swift; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2010-01-18       Impact factor: 2.398

Review 9.  Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.

Authors:  V Kiran Vemuri; David R Janero; Alexandros Makriyannis
Journal:  Physiol Behav       Date:  2007-11-21

10.  Associations Between Depression and Obesity in Parents and Their Late-Adolescent Offspring: A Community-Based Study.

Authors:  Naomi R Marmorstein; William G Iacono
Journal:  Psychosom Med       Date:  2016-09       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.